0000950170-24-065983.txt : 20240529 0000950170-24-065983.hdr.sgml : 20240529 20240529163320 ACCESSION NUMBER: 0000950170-24-065983 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240528 FILED AS OF DATE: 20240529 DATE AS OF CHANGE: 20240529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones Ryan Alexander CENTRAL INDEX KEY: 0002007219 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41947 FILM NUMBER: 24998892 MAIL ADDRESS: STREET 1: C/O KYVERNA THERAPEUTICS, INC. STREET 2: 5980 HORTON ST., SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kyverna Therapeutics, Inc. CENTRAL INDEX KEY: 0001994702 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831365441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5106268331 MAIL ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 ownership.xml 4 X0508 4 2024-05-28 0001994702 Kyverna Therapeutics, Inc. KYTX 0002007219 Jones Ryan Alexander C/O KYVERNA THERAPEUTICS, INC. 5980 HORTON ST., STE 550 EMERYVILLE CA 94608 false true false false Chief Financial Officer false Common Stock 2024-05-28 4 M false 10870 0.73 A 36804 D Common Stock 2024-05-28 4 M false 7146 0.73 A 43950 D Stock Option (Right to Buy) 0.73 2024-05-28 4 M false 10870 0 D Common Stock 10870 0 D Stock Option (Right to Buy) 0.73 2024-05-28 4 M false 7146 0 D Common Stock 7146 2192 D 25% of the original number of shares subject to the option vested on April 15, 2021, and 1/48th of the original number of shares subject to the option vested in monthly installments thereafter. 25% of the original number of shares subject to the option vested on January 1, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service. By: /s/ Ryan Jones 2024-05-29